Hudson Value Partners, LLC Pfizer Inc Transaction History

Hudson Value Partners, LLC

$229 Million
Q2 2024

A detailed history of Hudson Value Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hudson Value Partners, LLC holds 10,201 shares of PFE stock, worth $302,561. This represents 0.12% of its overall portfolio holdings.

Number of Shares

10,201

Previous 10,201 -0.0%

Holding current value

$302,561

Previous $283,000 0.71%

% of portfolio

0.12%

Previous 0.13%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $42,847 - $49,203	-1,655 Reduced 13.96%	10,201 $283,000
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $156,205 - $202,893	-5,978 Reduced 33.52%	11,856 $341,000
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $3,720 - $4,304	-103 Reduced 0.57%	17,834 $654,000
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $27,691 - $36,049	703 Added 4.08%	17,937 $731,000
Q4 2022 Jan 27, 2023	SELL	$41.75 - $54.5 $12,566 - $16,404	-301 Reduced 1.72%	17,234 $883,000
Q2 2022 Jul 29, 2022	SELL	$46.53 - $55.17 $91,664 - $108,684	-1,970 Reduced 10.1%	17,535 $919,000
Q1 2022 Apr 14, 2022	BUY	$45.75 - $56.69 $1,098 - $1,360	24 Added 0.12%	19,505 $1.01 Million
Q3 2021 Oct 29, 2021	BUY	$39.25 - $50.42 $11,775 - $15,126	300 Added 1.56%	19,481 $838,000
Q2 2021 Jul 09, 2021	BUY	$35.91 - $40.68 $6,248 - $7,078	174 Added 0.92%	19,181 $751,000
Q1 2021 Apr 19, 2021	SELL	$33.49 - $37.77 $33,490 - $37,770	-1,000 Reduced 5.0%	19,007 $689,000
Q4 2020 Feb 18, 2021	BUY	$33.47 - $42.56 $669,634 - $851,497	20,007 New	20,007 $735,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Value Partners, LLC with notifications on news.

Account

Hudson Value Partners, LLC Pfizer Inc Transaction History